Your browser doesn't support javascript.
loading
Colorectal leiomyosarcoma with BRCA2 mutation benefit from treatment with olaparib: a case report.
Hong, Lei; Wang, Ya-Nan; Zhang, Xue; Zhou, Xinliang; Fan, Shaoshuang; Xu, Mian; Zhang, Shanshan; Jiang, Da.
Afiliación
  • Hong L; Department of Medical Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
  • Wang YN; Pathology Department, Affiliated Hospital of Hebei University, Baoding, China.
  • Zhang X; Department of Medical Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
  • Zhou X; Department of Medical Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
  • Fan S; Department of Medical Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
  • Xu M; Shanghai OrigiMed Co., Ltd., Shanghai, China.
  • Zhang S; Shanghai OrigiMed Co., Ltd., Shanghai, China.
  • Jiang D; Department of Medical Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
J Gastrointest Oncol ; 13(3): 1499-1504, 2022 Jun.
Article en En | MEDLINE | ID: mdl-35837171
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: J Gastrointest Oncol Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: J Gastrointest Oncol Año: 2022 Tipo del documento: Article País de afiliación: China